Miltenyi Biotec promotes Markus Weiss to
Executive Vice President

Mr. Weiss will also continue to serve as
Chief Financial Officer North America,
a role he has held since 2020

Markus Weiss, who in this role is responsible for supporting the North American Business Units and Divisions has 18 years of experience in operationalizing strategy, preserving and growing value, scaling culture as well as business transformations. He is experienced in divisional, regional and country level leadership roles in technology, life science, manufacturing, construction and financial services.

Over the past two years Mr. Weiss had an opportunity of hiring over 100 team members due to the transition of Miltenyi Biotec’s North American Headquarter to Gaithersburg and the establishing of a state-of-the-art GMP Warehouse and Distribution facility that is going to support Miltenyi Biotec’s North American Divisions, including the Gaithersburg and San Jose based CDMOs.

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative technologies enable solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Miltenyi Biotec has about 4,000 employees in 28 countries.